These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 4720261)
21. [Results of Intencordin treatment of patients with coronary artery disease]. Adamska-Dyniewska H; Goch JH; Gajewska B Wiad Lek; 1973 Oct; 26(20):1937-40. PubMed ID: 4587344 [No Abstract] [Full Text] [Related]
22. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients. Sharma R; Mahajan M; Singh B; Bal BS; Kant R J Indian Med Assoc; 2006 Sep; 104(9):492-4, 496, 498. PubMed ID: 17388006 [TBL] [Abstract][Full Text] [Related]
23. [Evaluation of pyridinol carbamate treatment of coronary atherosclerosis]. Aguirre LV; Eseverri JL; Fajardo D; Ciliberti E; Quijano E; Lucerelli R Prensa Med Argent; 1970 Jun; 57(16):778-83. PubMed ID: 5457375 [No Abstract] [Full Text] [Related]
24. Aggressive medical therapy for the prevention and treatment of coronary artery disease. Malloy MJ; Kane JP Dis Mon; 1998 Jan; 44(1):1-40. PubMed ID: 9457050 [No Abstract] [Full Text] [Related]
25. Clinical evaluation of the effect of pyridinolcarbamate (Anginin) on ischemic heart diseases. Miyahara M; Ueda T Jpn Heart J; 1968 Jul; 9(4):359-67. PubMed ID: 5304316 [No Abstract] [Full Text] [Related]
26. [Atherosclerosis and simvastatin: new questions for the new millennium]. Tubaro M; Guido V; Sciarra L; Mustilli M; Carbone MA; D'Errico F Ann Ital Med Int; 2000; 15(1):108-14. PubMed ID: 10842900 [TBL] [Abstract][Full Text] [Related]
27. [Protective effect of carbamate pyridinol on experimental atheroma in the rat]. Bouissou H; Julian M; Pieraggi MT Pathol Biol (Paris); 1974 Oct; 22(8):713-20. PubMed ID: 4614172 [No Abstract] [Full Text] [Related]
28. Pathogenic mechanisms of atherosclerosis: effect of lipid lowering on the biology of atherosclerosis. Ganz P; Creager MA; Fang JC; McConnell MV; Lee RT; Libby P; Selwyn AP Am J Med; 1996 Oct; 101(4A):4A10S-16S. PubMed ID: 8900332 [TBL] [Abstract][Full Text] [Related]
29. Aggressive medical therapy for the prevention and treatment of coronary artery disease. Malloy MJ; Kane JP Adv Intern Med; 1997; 42():1-38. PubMed ID: 9048115 [No Abstract] [Full Text] [Related]
31. [Effect of xylite on clinico-biochemical indices in patients with coronary arteriosclerosis]. Chunakova EP Vrach Delo; 1971 Nov; 11():33-7. PubMed ID: 5143271 [No Abstract] [Full Text] [Related]
33. [The diagnosis and treatment of coronary heart disease in chronic renal failure]. Belialov FI Klin Med (Mosk); 2004; 82(10):8-12. PubMed ID: 15584591 [No Abstract] [Full Text] [Related]
34. [Verification of the lipid hypothesis by drug intervention]. Levy RI Ter Arkh; 1985; 57(11):33-5. PubMed ID: 3909475 [No Abstract] [Full Text] [Related]
36. [Evaluation of the effect of hypolipemic drugs in atherosclerosis]. Beaumont JL Nouv Presse Med; 1980 Oct; 9(40):2945-6. PubMed ID: 7443427 [No Abstract] [Full Text] [Related]
37. [Therapeutic trial with plasmaclar in arteriosclerotic patients and modification of their cholesterol rates]. Casado Salvador F Folia Clin Int (Barc); 1976 Sep; 26(9):415-9. PubMed ID: 793885 [No Abstract] [Full Text] [Related]
38. Regression of atherosclerotic renal artery stenosis with aggressive lipid lowering therapy. Khong TK; Missouris CG; Belli AM; MacGregor GA J Hum Hypertens; 2001 Jun; 15(6):431-3. PubMed ID: 11439320 [No Abstract] [Full Text] [Related]
39. [The role of hypolipidaemic agents in the fight against atherosclerosis (author's transl)]. Jacotot B Nouv Presse Med; 1980 Oct; 9(40):2951-4. PubMed ID: 7443429 [No Abstract] [Full Text] [Related]
40. [Clinical trial of the new coronary dilator hexobendine]. Henke C; Dudik E; Steim H Arzneimittelforschung; 1968 Aug; 18(8):1103-7. PubMed ID: 4885101 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]